Achieving Product Launch Potential for Large Pharma

Introduction

With the prevalence of cancers increasing, the treatment landscape has also shifted. Oncology drug launches are ever more critical and require a dedicated approach. For this reason, a large biotech and pharma company engaged Herspiegel for their product launch planning for a late oncology entrant in an established category.

The Problem

A biotech and large pharma company partnered with Herspiegel to commercialize a new oncology asset. The launch teams needed a cohesive launch plan reflecting all activities to be completed for launch readiness.

Our Solution

• Herspiegel evolved a straw-man product launch plan across functions to align to the asset development milestones, market opportunity and strategy.
• Working sessions were facilitated with the alliance partners to review and finalize the launch plan by function, then a whole team review of the full plan and inter-dependencies was held.
• Developed and tracked the risk and mitigation plan.
• Established a governance process for product launches; managing project workstreams and teams to ensure rapid and seamless integration of internal and external stakeholders with timely updates to senior management.

Value Delivered

• Launch strategies that offered proper direction to a team with competing priorities.
• Clear and concise plans: delivered detailed strategy, key initiatives, and tactics ensuring alignment and coordination.
• Successful product launches within a competitive market brand, exceeding revenue goals by ~25%.